Clinical Research  

 

The following studies are in development and undergoing IRB submission and review 

 

  • RIKEE1:                  Genotype/ phenotype correlations in KCNQ2 associated epilepsy                                           and developmental delay

 

  • RIKEE2:                   Phase 1 study of ezogabine in infants and children 

 

 

  • RIKEE 3:                  Phase 2/ 3 study of ezogabine in infants and children

 

 

 

Laboratory Research

 

The Molecular Neuropharmacology Lab at Baylor College of Medicine is studying the consequences of Q2 Deficiency mutations and testing therapies using in vitro and in vivo rodent models.

 

 

DO YOU REALLY WANT TO INCLUDE CURRENT RESEARCH TAB?

© 2015-2020  Edward C. Cooper All rights reserved